Marshall Wace North America’s Bicycle Therapeutics BCYC Stock Holding History

Marshall Wace North America’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$726K	Buy	+17,458	New	+$611K	﹤0.01%	1028
2021 Q2	–	Sell	-91,640	Closed	-$2.74M	–	1459
2021 Q1	$2.74M	Buy	91,640 +59,073	+181%	+$1.52M	0.01%	726
2020 Q4	$585K	Buy	+32,567	New	+$629K	﹤0.01%	1052

Other funds holding BCYC

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return